Literature DB >> 12042948

Ultrasound and magnetic resonance imaging in Crohn's disease: a comparison.

S Potthast1, A Rieber, C Von Tirpitz, D Wruk, G Adler, H-J Brambs.   

Abstract

The objective of this retrospective study was to compare MRI of the abdomen with ultrasound of the abdomen and gastrointestinal tract in patients with Crohn's disease. Forty-six patients were included in the study. We analyzed the localization of Crohn's lesions, the number of affected bowel segments, the number of stenoses, and the presence of abscesses, fistulae, and any additional findings. Findings were verified by means of one or more of the following: enteroclysis; surgical findings; and colonoscopy. The results show that MRI is superior to ultrasound in the localization of affected bowel segments (sensitivity: MRI 97.5%; US 76%) and in recognizing fistulae (sensitivity: MRI 87%; US 31%), stenoses (sensitivity: MRI 100%; US 58%) and abscesses (sensitivity: MRI 100%; US 89%). Magnetic resonance imaging of the abdomen should be obtained to clarify discrepant clinical and sonographic findings. In addition, despite its higher cost, MRI of the abdomen is justified in patients in whom Crohn's lesions are known or suspected in anatomic areas proximal to the terminal or neoterminal ileum and in cases with suspicion of fistulae and abscesses.

Entities:  

Mesh:

Year:  2001        PMID: 12042948     DOI: 10.1007/s00330-001-1191-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

Review 1.  Ultrasonography of Crohn disease in children.

Authors:  Marianne Alison; Ahmed Kheniche; Robin Azoulay; Sandrine Roche; Guy Sebag; Nadia Belarbi
Journal:  Pediatr Radiol       Date:  2007-09-25

Review 2.  CT and MRI of paediatric Crohn disease.

Authors:  Paolo Toma; Claudio Granata; Gianmichele Magnano; Arrigo Barabino
Journal:  Pediatr Radiol       Date:  2007-09-25

3.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 4.  Bowel ultrasound in Crohn's disease: surgical perspective.

Authors:  Giovanni Maconi; Gianluca M Sampietro; Alessandra Sartani; Gabriele Bianchi Porro
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

5.  Enterclysis versus enterography: the unsettled issue.

Authors:  Michael R Torkzad; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2008-08-06       Impact factor: 5.315

6.  Detecting inflammation in inflammatory bowel disease - how does ultrasound compare to magnetic resonance enterography using standardised scoring systems?

Authors:  Joy L Barber; Alexsandra Zambrano-Perez; Øystein E Olsen; Fevronia Kiparissi; Mila Baycheva; Daniela Knaflez; Neil Shah; Tom A Watson
Journal:  Pediatr Radiol       Date:  2018-04-13

7.  Polyethylene glycol and contrast-enhanced MRI of Crohn's disease in children: preliminary experience.

Authors:  Gianmichele Magnano; Claudio Granata; Arrigo Barabino; Francesca Magnaguagno; Umberto Rossi; Maria Grazia Calevo; Paolo Toma
Journal:  Pediatr Radiol       Date:  2003-04-05

8.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

9.  High-output fistula.

Authors:  Naila Arebi; Alastair Forbes
Journal:  Clin Colon Rectal Surg       Date:  2004-05

10.  Frequency and nature of incidental extra-enteric lesions found on magnetic resonance enterography (MR-E) in patients with inflammatory bowel diseases (IBD).

Authors:  Hans H Herfarth; Michael Grunert; Frank Klebl; Ulrike Strauch; Stefan Feuerbach; Jürgen Schölmerich; Gerhard Rogler; Andreas G Schreyer
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.